title: Imported fire ant rush desensitization using omalizumab and a premedication regimen.
authors.affiliation: Department of Pediatrics, RAF Lakenheath Medical Center, Lakenheath, England.
authors.forename: Katherine S
authors.initials: KS
authors.lastname: Tille
authors.affiliation: Department of Allergy and Immunology, Landstuhl Regional Medical Center, Landstuhl, Germany. Electronic address: Amy.parker.1@us.af.mil.
authors.forename: Amy L
authors.initials: AL
authors.lastname: Parker
mesh_terms: D000328:Adult; D000818:Animals; D000862:Ant Venoms / Q000008:administration & dosage*; D018926:Anti-Allergic Agents / Q000008:administration & dosage*; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D001000:Ants / Q000276:immunology*; D003888:Desensitization, Immunologic / Q000379:methods*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D000069444:Omalizumab; D011247:Pregnancy; D011248:Pregnancy Complications / Q000276:immunology / Q000517:prevention & control
chemical_list: D000862:Ant Venoms; D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab